Understanding how specific genetic variants in KCNH2 affect heart rhythm disorders
Integrating KCNH2 Variant-Specific Features and Heterozygote Phenotypes to Estimate Long QT Penetrance
This study is looking at how certain changes in a gene important for heart health might affect the risk of long QT syndrome and heart rhythm problems, especially in women after giving birth, to help us understand how these genetic factors can influence the severity of the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11010412 on NIH RePORTER |
What this research studies
This research investigates the impact of specific genetic variants in the KCNH2 gene, which is crucial for heart function, on the risk of long QT syndrome and related heart rhythm disorders. By analyzing genetic data, the study aims to better understand how these variants influence disease severity and penetrance, particularly in individuals who carry one copy of the variant. The approach includes advanced statistical models to interpret genetic information and assess the associated risks for affected individuals, especially women during the postpartum period.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with known KCNH2 genetic variants or those with a family history of long QT syndrome.
Not a fit: Patients without KCNH2 variants or those not at risk for heart rhythm disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved risk assessment and personalized treatment strategies for individuals with KCNH2 variants, potentially reducing the incidence of sudden cardiac events.
How similar studies have performed: Previous research has shown promising results in understanding genetic variants related to heart conditions, indicating that this approach could yield valuable insights.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Kroncke, Brett M — Vanderbilt University Medical Center
- Study coordinator: Kroncke, Brett M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.